Date of report (Date of earliest event reported): December 17, 2012
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On December 17, 2012, MyMedicalRecords, Inc. (the "Company") executed a Non-Exclusive Patent License Agreement (the "Agreement") with Healthcare Holdings Group, Inc. ("Licensee") to license certain rights in the Company's Health IT patents, including, but not limited to: U.S. Patent No. 8,321,240; U.S. Patent No. 8,301,466; U.S. Patent No. 8,117,045; U.S. Patent No. 8,117,646; and U.S. Patent No. 8,121,855, as well as any other Health IT patents to be issued pursuant to pending applications filed by the Company in the United States and all divisions, continuations, reissues and extensions thereof (collectively, the "Licensed Patents"). The Agreement expires simultaneously with the last to expire of the Licensed Patents.
The Licensee will utilize the rights granted under the Licensed Patents in connection with its Health IT business, including Licensee's products and services directed to healthcare professionals, including ChartZoneMD ("ChartZoneMD"), an Electronic Health Records ("EHR") cloud-based software solution, SmartFormsMD ("SmartFormsMD"), a new voice-over commanded software module, and AccessMyRecords.com ("AMR"), an electronic storage and retrieval service for medical and legal records that serves as the patient portal for the ChartZoneMD EHR software suite, and other such products and services embodied in the Licensed Patents.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.